Novira Therapeutics Completes $25 Million Series A Financing
Read more here
News
Relmada Therapeutics Announces Levocap ER Development Progress
Read more here
Ceptaris Resubmits New Drug Application (NDA) to FDA for Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here
Merganser: Hip to Hep
Read more here
Pennsylvania Has Enormous Untapped Potential for Investment, Says Venture Capitalist Kush Parmar
Read more here
Optofluidics Announces Pre-release of Molecular NanoTweezer System
Read more here
Ceptaris Announces Publication in JAMA Dermatology of Positive Clinical Results
Read more here
NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Read more here
InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
Read more here
FDA is Readying to Rule on NuPathe’s Revised Application for its Patch to Treat Migraines
Read more here